Tern Therapeutics
PrivateLast Round
Series A
Aug 27, 2024
Total Funding Raised
$15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tern Therapeutics operates in Healthcare & Life Sciences and is based in Washington D.C.. Its latest recorded funding round was a Series A round in August 2024.
Tern Therapeutics is a biotechnology company that develops transformative, one-time gene therapy medicines for rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tern Therapeutics Comparables
Compare Tern Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neela Therapeutics | 84% | |
| LEXEO Therapeutics | 80% | |
| Abeona Therapeutics Inc. | 78% |
For institutional investors. Book with your work email.
Tern Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tern Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ATW Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 225% MoM, reaching 1.9K.
- Apr 15, 2026
Monthly visitors grew 111% MoM.
For institutional investors. Book with your work email.
Tern Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tern Therapeutics's valuation, stock price, and market status.
Is Tern Therapeutics a public or private company?
Tern Therapeutics is a private company.
What is the current stock price of Tern Therapeutics?
Tern Therapeutics is a private company, so its shares have no public market price. Caplight tracks Tern Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tern Therapeutics worth (valuation)?
Valuation information for Tern Therapeutics is not publicly available.
Can I buy Tern Therapeutics stock?
Tern Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tern Therapeutics's last funding round?
Tern Therapeutics's most recent funding round was Series A on August 27, 2024.
Who are the main investors in Tern Therapeutics?
Key investors in Tern Therapeutics include ATW Partners.
Will Tern Therapeutics IPO soon?
No public IPO plans have been announced for Tern Therapeutics.
How can I track Tern Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Tern Therapeutics's shares on secondary markets.